Apyx Medical Corp APYX

NAS: APYX | ISIN: US03837C1062   22:00
1,410 USD (+0,71%)
(+0,71%)   22:00

2 mei 2023 · Renuvion® Receives Fda Clearance For Specific Use After Liposuction · Persbericht

27 maart 2023 · Renuvion Wins ADDY® Award for #ThisIsMe Campaign · Persbericht

9 februari 2023 · Renuvion® Cosmetic Neck Laxity Procedure To Be Featured On 'The Balancing Act' Talk Show On Lifetime® February 13 · Persbericht

25 januari 2023 · Apyx Medical Corporation Launches New 'Apyx One Console' For Cosmetic Surgical Procedures In The United States · Persbericht

3 januari 2023 · Apyx® Medical Corporation Embarks On Inaugural Brand Campaign For Renuvion® · Persbericht

13 september 2022 · 'Botched' Tv Star Dr. Paul Nassif Among Top U.s. Plastic Surgeons Using Renuvion® Helium Plasma Technology In Cosmetic Procedures · Persbericht

2 augustus 2022 · APYX Investors Have Opportunity to Lead Apyx Medical Corporation Securities Fraud Lawsuit · Persbericht

21 juli 2022 · Berger Montague Securities Fraud Investigation: APYX MEDICAL CORPORATION - Apyx Medical Corp. (NASDAQ: APYX); Lead Plaintiff Deadline is August 5, 2022 · Persbericht

18 juli 2022 · Renuvion® Cleared By Fda For Neck Laxity Procedures Offering Patients A Minimally Invasive Option To Eliminate Sagging Neck · Persbericht

30 juni 2022 · APYX MEDICAL CORPORATION Company News: Berger Montague Investigates Securities Fraud Allegations Against Apyx Medical Corp. (NASDAQ: APYX); Lead Plaintiff Deadline is August 5, 2022 · Persbericht

28 juni 2022 · Renuvion® Dermal Handpiece For Wrinkle-Reduction Procedures Cleared By Fda · Persbericht

15 juni 2022 · APYX Investors Have Opportunity to Lead Apyx Medical Corporation Securities Fraud Lawsuit · Persbericht

Mijn selecties